GLP-1 SM: GLP-1 Receptor Agonist Research Overview

GLP-1 (glucagon-like peptide-1) is an incretin hormone secreted by intestinal L-cells in response to food intake. The endogenous GLP-1(7-37) and GLP-1(7-36)NH₂ peptides bind the GLP-1 receptor (GLP-1R) on pancreatic beta cells, central nervous system neurons, and several other tissues, producing glucose-dependent insulin secretion, central appetite signaling, and other downstream effects.^[1]

Synthetic GLP-1 receptor agonists were developed to address the short half-life of native GLP-1 (approximately 2 minutes due to rapid DPP-4 cleavage). These analogs use various structural modifications — backbone substitutions, fatty acid acylation, PEGylation — to extend in vivo activity for both research and clinical applications.^[2]

GLP-1 SM is studied as a research reference compound. While clinical GLP-1 receptor agonists have approved therapeutic indications, research-grade GLP-1 SM material is supplied for laboratory research only.

GLP-1 SM is a synthetic peptide based on the GLP-1 backbone with modifications for stability and receptor engagement:

• Backbone: based on the GLP-1(7-37) active sequence

• Modifications: typically includes a substitution at position 8 (Aib for Ala) to resist DPP-4, plus a fatty acid acylation via gamma-Glu linker for albumin binding

• Length: approximately 30-31 amino acids

• Form: lyophilized solid

The Aib substitution at position 8 (relative to GLP-1[7-37] numbering, this is the second residue) is the canonical modification to block DPP-4 cleavage at the N-terminal dipeptide. This single change extends in vitro stability dramatically.^[2]

Fatty acid acylation provides reversible binding to serum albumin, which further extends half-life by shielding the peptide from renal clearance and providing a circulating depot. The fatty acid chain length and the linker chemistry affect the exact binding affinity for albumin.^[3]

GLP-1 SM's research-characterized activity is at the GLP-1 receptor.

GLP-1R is a class B G-protein-coupled receptor. Activation produces cAMP accumulation via Gs coupling, with downstream PKA pathway engagement. In pancreatic beta cells, this signaling leads to glucose-dependent insulin secretion.^[1]

GLP-1R is expressed in multiple tissues beyond beta cells, including central neurons (where it contributes to satiety signaling), cardiomyocytes, and some immune cells. Research studies use tissue-specific cell models to dissect the various GLP-1R-mediated effects.^[4]

A subset of GLP-1R research examines functional selectivity (biased agonism) — whether different agonists produce different ratios of downstream signaling outputs (cAMP vs beta-arrestin recruitment, for example). This is an active area of synthetic GLP-1 analog research.^[5]

GLP-1 receptor agonist literature is one of the largest in metabolic peptide research.

Isolated pancreatic islet preparations and beta cell lines (INS-1, MIN6) are common substrates for GLP-1 SM research. Endpoints include glucose-stimulated insulin secretion, beta cell proliferation markers, and apoptosis assays under controlled conditions.^[1][4]

Rodent models of food intake and body weight regulation have used GLP-1 receptor agonists to probe central satiety pathways. Hypothalamic and brainstem signaling assays are typical endpoints.^[4]

GLP-1 SM is studied in combination with amylin analogs (Cagrilintide), GIP receptor agonists, and dual/tri-agonist molecules to map the broader incretin and metabolic hormone network.^[6]

GLP-1 SM's structural modifications provide enhanced stability over native GLP-1. Standard peptide handling practices apply.

Lyophilized material is stored at minus 20 degrees Celsius. Refrigerated storage at 4 degrees Celsius is acceptable for actively used material.

Bacteriostatic water is the standard reconstitution solvent. Reconstituted solution is used within 4 to 6 weeks at 4 degrees Celsius.

HPLC for purity (≥99%), mass spectrometry for identity confirmation (including the fatty acid modification mass), and endotoxin screening. Each batch of Instant Peptides GLP-1 SM ships with a full Certificate of Analysis.

Instant Peptides supplies GLP-1 SM as a synthetic lyophilized reference compound in 10mg vials. Material is supplied to qualified research professionals. Not for human or animal consumption.

View the product page for current pricing and the Certificate of Analysis for the active batch.